Ariel Hurley Blueprint Medicines Corp (BPMC) insider trading activity

Ariel Hurley is PRINCIPAL ACCOUNTING OFFICER of Blueprint Medicines Corp. Currently has a direct ownership of 14,967 shares of BPMC, which is worth approximately $1.35 Million. The most recent transaction as insider was on Dec 12, 2024, when has been sold 1,819 shares (Common Stock) at a price of $93.43 per share, resulting in proceeds of $169,949. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15K

0.36% 3M change

4.49% 12M change

Total Value Held $1.35 Million

Ariel Hurley Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 12 2024	SELL Open market or private sale	$169,949 $93.43 p/Share	1,819 Reduced 10.84%	14,967 Common Stock
Dec 12 2024	BUY Exercise of conversion of derivative security	$24,016 $15.01 p/Share	1,600 Added 8.7%	16,786 Common Stock
May 15 2024	SELL Open market or private sale	$625,947 $106.89 p/Share	5,856 Reduced 28.2%	14,913 Common Stock
May 15 2024	BUY Exercise of conversion of derivative security	$231,897 $39.6 p/Share	5,856 Added 21.99%	20,769 Common Stock
May 02 2024	SELL Open market or private sale	$190,515 $103.88 p/Share	1,834 Reduced 10.95%	14,913 Common Stock
May 02 2024	BUY Exercise of conversion of derivative security	$99,274 $54.13 p/Share	1,834 Added 9.87%	16,747 Common Stock
Mar 15 2024	SELL Open market or private sale	$401,176 $88.19 p/Share	4,549 Reduced 23.37%	14,913 Common Stock
Mar 15 2024	BUY Exercise of conversion of derivative security	$24,016 $15.01 p/Share	1,600 Added 7.9%	18,662 Common Stock
Mar 07 2024	SELL Open market or private sale	$132,588 $90.69 p/Share	1,462 Reduced 7.57%	17,862 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	5,000 Added 20.56%	19,324 Common Stock
Dec 22 2023	SELL Open market or private sale	$64,260 $90.0 p/Share	714 Reduced 4.75%	14,324 Common Stock
Dec 22 2023	BUY Exercise of conversion of derivative security	$6,283 $8.8 p/Share	714 Added 4.53%	15,038 Common Stock
Dec 15 2023	SELL Open market or private sale	$330,145 $84.35 p/Share	3,914 Reduced 21.46%	14,324 Common Stock
Dec 15 2023	BUY Exercise of conversion of derivative security	$6,832 $1.87 p/Share	3,654 Added 18.21%	16,411 Common Stock
Mar 06 2023	SELL Open market or private sale	$50,737 $45.06 p/Share	1,126 Reduced 7.36%	14,175 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	5,425 Added 26.17%	15,301 Common Stock
Mar 10 2022	SELL Open market or private sale	$133,674 $57.15 p/Share	2,339 Reduced 19.57%	9,616 Common Stock
Mar 07 2022	SELL Open market or private sale	$14,385 $56.19 p/Share	256 Reduced 2.1%	11,955 Common Stock
Mar 03 2022	SELL Open market or private sale	$45,865 $60.27 p/Share	761 Reduced 5.87%	12,211 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	2,875 Added 18.14%	12,972 Common Stock
Nov 16 2021	SELL Open market or private sale	$222,846 $114.28 p/Share	1,950 Reduced 16.19%	10,097 Common Stock
Nov 16 2021	BUY Exercise of conversion of derivative security	$16,692 $8.56 p/Share	1,950 Added 13.93%	12,047 Common Stock
Sep 23 2021	SELL Open market or private sale	$66,000 $110.0 p/Share	600 Reduced 5.61%	10,097 Common Stock
Sep 23 2021	BUY Exercise of conversion of derivative security	$9,006 $15.01 p/Share	600 Added 5.31%	10,697 Common Stock
Sep 13 2021	SELL Open market or private sale	$60,000 $100.0 p/Share	600 Reduced 5.61%	10,097 Common Stock

Ariel Hurley

PRINCIPAL ACCOUNTING OFFICER

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Value

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

Operation

Value

Type

News

Receive news related to Blueprint Medicines Corp

Track Activities on BPMC

Account